Search the GHTC website

Valneva is a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. Our vision is to contribute to a world in which no one dies or suffers from a vaccine-preventable disease. Valneva is led by a Management Board and a Supervisory Board and is listed on Euronext Paris and on Nasdaq.